Sanofi to acquire UK-based biopharma company Kymab in $1.4bn worth deal
(adsbygoogle = window.adsbygoogle || []).push({}); Sanofi acquisition of Kymab : French pharma giant Sanofi has signed a deal worth up to $1.45 billion to acquire Kymab, a UK-based clinical-stage More...
Acadia Healthcare to sell Priory Group to Waterland Private Equity for $1.47bn
Acadia Healthcare, a US-based behavioral healthcare provider, has agreed to sell its UK operations – The Priory Group to private equity investment group Waterland Private Equity for around £1.07 billion More...
HGGC to acquire specialist insurance broker Specialist Risk Group
UK-based specialist insurance broker Specialist Risk Group (SRG) has agreed to be acquired by US-based middle-market private equity firm HGGC for an undisclosed price. Specialist Risk Group’s management team will More...
Cisco to acquire cloud communications software firm IMImobile for $735m
US technology conglomerate Cisco has agreed to acquire UK-based cloud communications software and services provider IMImobile for 595 pence per share or nearly $730 million in cash, including debt of the latter. IMImobile More...
PharmaEngine, Sentinel Oncology partner to advance SOL-578 Chk1 inhibitor
PharmaEngine has signed a collaboration and license deal with UK-based Sentinel Oncology for advancing the new drug development of SOL-578, a checkpoint kinase 1 inhibitor (Chk1 inhibitor). As per the agreement, More...
Dogger Bank offshore wind project : Eni to acquire 20% stake in phases A and B for £405m
Italian oil and gas giant Eni is foraying into the UK offshore wind market by acquiring a 20% stake in the 2.4GW Dogger Bank offshore wind project A and B assets from Equinor and SSE Renewables for £405 million. Brief More...
S&P Global to acquire information provider IHS Markit for $44bn
S&P Global acquisition of IHS Markit : S&P Global, a US financial information and analytics provider, has agreed to acquire London-based information provider IHS Markit in an all-stock deal worth $44 billion, More...
NaQuinate : Haoma Medica completes human trial of osteoporosis candidate
Haoma Medica has wrapped up a first-in-human trial for NaQuinate, a naphthoquinone carboxylic acid, which is being developed as an oral treatment for osteoporosis. The UK-based biotech company initiated the human More...
PostEra, NeuroLucent to partner on identifying small-molecule therapeutics for Alzheimer’s
PostEra, a UK-based biotech company, has entered into a collaboration with NeuroLucent, a US company focused on developing drugs for the treatment of Alzheimer’s disease and other dementias. NeuroLucent is More...
Intact Financial and Tryg to acquire British insurer RSA for £7.2bn
Intact Financial, a Canadian insurance giant, and Danish insurance company Tryg have struck a deal to acquire British insurance group RSA for nearly £7.2 billion in cash. RSA operates in the general insurance markets More...